Volume 1, Issue 1

2014pp 1—110

News

Introducing Oncoscience: from Oncotarget to the future

https://doi.org/10.18632/oncoscience.14

PDF

Editorials

Targeting glutamine uptake in AML

Nathalie Jacque, Didier Bouscary

https://doi.org/10.18632/oncoscience.1pp 1—2

PDF Full-Text

MicroRNA in drug resistance

Haoran Li, Burton B. Yang

https://doi.org/10.18632/oncoscience.2pp 3—4

PDF Full-Text

Research Papers

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

Chad Tang, Denis L. Fontes Jardim, Gerald S. Falchook, Kenneth Hess, Siqing Fu, Jennifer J. Wheler, Ralph G. Zinner, Aung Naing, Apostolia M. Tsimberidou, Debora De Melo Galgiato, Shannon N. Westin, Funda Meric-Bernstam, Razelle Kurzrock, David S. Hong

https://doi.org/10.18632/oncoscience.3pp 5—13

View Abstract PDF Full-Text

Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast

Otavia L. Caballero, Sami Shousha, Qi Zhao, Andrew J. G. Simpson, R. Charles Coombes, A. Munro Neville

https://doi.org/10.18632/oncoscience.4pp 14—20

View Abstract PDF Full-Text

Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition

Margarita Papaioannou, Ioannis Mylonas, Richard E. Kast, Ansgar Bruning

https://doi.org/10.18632/oncoscience.5pp 21—29

View Abstract PDF Full-Text

Interplay between HGF/SF‒Met-Ras signaling, tumor metabolism and blood flow as a potential target for breast cancer therapy

Sari Natan, Galia Tsarfaty, Judith Horev, Roni Haklai, Yoel Kloog, Ilan Tsarfaty

https://doi.org/10.18632/oncoscience.6pp 30—38

View Abstract PDF Full-Text

Novel LIMK2 inhibitor blocks Panc-1 tumor growth in a mouse xenograft model

Roni Rak, Roni Haklai, Galit Elad-Tzfadia, Haim J. Wolfson, Shmuel Carmeli, Yoel Kloog

https://doi.org/10.18632/oncoscience.7pp 39—48

View Abstract PDF Full-Text

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients

Elisabetta Rossi, Massimo Rugge, Antonella Facchinetti, Marco Pizzi, Giorgia Nardo, Vito Barbieri, Mariangela Manicone, Stefania De Faveri, Maria Chiara Scaini, Umberto Basso, Alberto Amadori, Rita Zamarchi

https://doi.org/10.18632/oncoscience.8pp 49—56

View Abstract PDF Full-Text

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors

Djamel Aggoune, Lucie Tosca, Nathalie Sorel, Marie-Laure Bonnet, Fatima Dkhissi, Gerard Tachdjian, Annelise Bennaceur-Griscelli, Jean-Claude Chomel, Ali G. Turhan

https://doi.org/10.18632/oncoscience.9pp 57—68

View Abstract PDF Full-Text

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer

Ridha Limame, Ken Op de Beeck, Steven Van Laere, Lieselot Croes, Annemieke De Wilde, Luc Dirix, Guy Van Camp, Marc Peeters, Olivier De Wever, Filip Lardon, Patrick Pauwels

https://doi.org/10.18632/oncoscience.10pp 69—81

View Abstract PDF Full-Text